blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3021881

EP3021881 - CROSS-LINKED HYALURONIC ACID, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THE AESTHETIC FIELD [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.02.2018
Database last updated on 29.06.2024
FormerThe patent has been granted
Status updated on  10.03.2017
FormerGrant of patent is intended
Status updated on  07.12.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
I.R.A. Istituto Ricerche Applicate S.r.l.
Via del Lavoro 4A/6
20040 Usmate Velate / IT
[2016/21]
Inventor(s)01 / CITERNESI, Ugo Raffaello
Via alla Chiesa 1
I-23881 Airuno / IT
02 / BERETTA, Lorenzo
Via Caduti per la Patria 42
I-20855 Lesmo / IT
03 / CITERNESI, Lorenzo
Via alla Chiesa 1
I-23881 Airuno / IT
 [2016/21]
Representative(s)Coppo, Alessandro, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2016/21]Coppo, Alessandro, et al
Notarbartolo & Gervasi S.P.A. Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date14753022.416.07.2014
[2016/21]
WO2014EP65237
Priority number, dateIT2013MI0119316.07.2013         Original published format: IT MI20131193
[2016/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015007773
Date:22.01.2015
Language:EN
[2015/03]
Type: A1 Application with search report 
No.:EP3021881
Date:25.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 22.01.2015 takes the place of the publication of the European patent application.
[2016/21]
Type: B1 Patent specification 
No.:EP3021881
Date:12.04.2017
Language:EN
[2017/15]
Search report(s)International search report - published on:EP22.01.2015
ClassificationIPC:A61L27/20
[2016/21]
CPC:
A61K8/735 (EP,RU,US); A61K8/42 (EP,RU,US); A61L27/20 (EP,RU,US);
A61Q19/08 (EP,RU,US); C08B37/0072 (RU,US); A61K2800/74 (US);
A61K2800/91 (EP,US); A61K2800/95 (US); A61L2400/06 (EP,US);
A61L2430/34 (EP,US) (-)
C-Set:
A61L27/20, C08L5/08 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/21]
Extension statesBA15.02.2016
ME15.02.2016
TitleGerman:VERNETZTE HYALURONSÄURE, VERFAHREN ZUR HERSTELLUNG DAVON UND VERWENDUNG DAVON AUF DEM GEBIET DER ÄSTHETIK[2016/21]
English:CROSS-LINKED HYALURONIC ACID, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THE AESTHETIC FIELD[2016/21]
French:ACIDE HYALURONIQUE RÉTICULÉ, PROCÉDÉ DE PRÉPARATION DE CELUI-CI ET UTILISATION DE CET ACIDE DANS LE DOMAINE DE L'ESTHÉTIQUE[2016/21]
Entry into regional phase15.02.2016National basic fee paid 
15.02.2016Designation fee(s) paid 
15.02.2016Examination fee paid 
Examination procedure11.05.2015Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.02.2016Examination requested  [2016/21]
15.09.2016Amendment by applicant (claims and/or description)
08.12.2016Communication of intention to grant the patent
03.03.2017Fee for grant paid
03.03.2017Fee for publishing/printing paid
03.03.2017Receipt of the translation of the claim(s)
Opposition(s)15.01.2018No opposition filed within time limit [2018/12]
Fees paidRenewal fee
11.07.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.07.2014
AL12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
TR12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
[2020/34]
Former [2020/15]HU16.07.2014
CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
TR12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
Former [2019/52]HU16.07.2014
CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
Former [2019/31]HU16.07.2014
CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
Former [2019/30]CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
Former [2018/34]CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
LU16.07.2017
IS12.08.2017
Former [2018/25]CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
IS12.08.2017
Former [2018/11]CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
IS12.08.2017
Former [2018/10]CZ12.04.2017
DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
RS12.04.2017
SE12.04.2017
SK12.04.2017
BG12.07.2017
NO12.07.2017
IS12.08.2017
Former [2018/09]DK12.04.2017
EE12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RS12.04.2017
SE12.04.2017
BG12.07.2017
NO12.07.2017
IS12.08.2017
Former [2017/50]FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RS12.04.2017
SE12.04.2017
BG12.07.2017
NO12.07.2017
IS12.08.2017
Former [2017/49]FI12.04.2017
HR12.04.2017
LT12.04.2017
NL12.04.2017
NO12.07.2017
IS12.08.2017
Former [2017/48]NL12.04.2017
Cited inInternational search[X]GB2151244  (BIOMATRIX INC);
 [A]US5529987  (GALLINA DAMIAN J [US]);
 [A]WO2005067994  (ANIKA THERAPEUTICS INC [US], et al);
 [X]WO2012028863  (FUJIFILM MFG EUROPE BV [NL], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.